Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
2
Ask the Expert: Complying with Standards
3
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
4
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
5